BlackRock Health Sciences Trust Plans Monthly Dividend of $0.26 (NYSE:BME)

BlackRock Health Sciences Trust (NYSE:BME) announced a monthly dividend on Friday, June 5th. Shareholders of record on Wednesday, July 15th will be paid a dividend of 0.2621 per share on Friday, July 31st. This represents a c) annualized dividend and a yield of 7.3%. The ex-dividend date is Wednesday, July 15th.

BlackRock Health Sciences Trust Stock Up 0.0%

Shares of NYSE BME opened at $43.03 on Monday. BlackRock Health Sciences Trust has a 12-month low of $35.03 and a 12-month high of $44.35. The stock’s fifty day simple moving average is $40.54 and its two-hundred day simple moving average is $40.71.

Hedge Funds Weigh In On BlackRock Health Sciences Trust

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Sound Income Strategies LLC bought a new position in BlackRock Health Sciences Trust in the first quarter worth about $36,000. Northwestern Mutual Wealth Management Co. grew its position in shares of BlackRock Health Sciences Trust by 22.2% in the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 1,417 shares of the company’s stock worth $53,000 after buying an additional 257 shares during the last quarter. Fifth Third Bancorp bought a new position in shares of BlackRock Health Sciences Trust during the 1st quarter worth approximately $180,000. Geneos Wealth Management Inc. lifted its position in BlackRock Health Sciences Trust by 200.0% during the second quarter. Geneos Wealth Management Inc. now owns 4,899 shares of the company’s stock valued at $179,000 after acquiring an additional 3,266 shares during the last quarter. Finally, Money Concepts Capital Corp acquired a new stake in BlackRock Health Sciences Trust in the first quarter valued at approximately $209,000.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.